2-Methoxyacridin-9-amine
- Molecular formula
- C14H12N2O
- CAS Number
- 607-82-9
- IUPAC Name
- 2-methoxyacridin-9-amine
- Molecular Weight
- 236.28g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2670g/cm3
- Appearance
- is reflective of many aromatic amines, possessing a vitreous shine or sheen under light.
- Synonyms
- ACRIDINE, 9-AMINO-2-METHOXY-
Identification
Exploring 2-Methoxyacridin-9-amine
2-Methoxyacridin-9-amine is a fascinating compound that falls under the category of acridine derivatives, which are known for their extensive applications in various fields of science. This compound exhibits unique properties that make it a subject of interest in both medicinal chemistry and materials science.
Key Facts
- Biological Relevance: Compounds similar to 2-methoxyacridin-9-amine have demonstrated significant biological activity, including anti-cancer and anti-viral properties. Studies have indicated that they can interact with DNA, potentially interfering with cellular processes.
- Fluorescent Properties: This compound shows potential in fluorescence applications due to its conjugated structure. Its ability to emit light makes it useful in bioimaging and fluorescence microscopy.
- Synthetic Applications: The synthesis of 2-methoxyacridin-9-amine often involves various organic reactions, allowing chemists to explore diverse methodologies and enhancing their synthetic skills.
- Research Potential: Ongoing research is being conducted to examine the compound's properties and develop novel derivatives that can enhance its efficacy in medical applications.
In summary, 2-methoxyacridin-9-amine is more than just a simple chemical compound; it is a gateway to exploring the realms of biology and material science. Its unique characteristics provide ample opportunities for researchers and students alike to make groundbreaking discoveries. As noted in scientific literature, "The future of acridine derivatives like 2-methoxyacridin-9-amine is bright, holding promise for advancements in therapeutic treatments."